Bing Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bing Lu has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
- Yong Yao
School of Chemistry and Chemical Engineering, Nantong University, Nantong, China
23 shared publications - Yang Wang
School of Chemistry and Chemical Engineering, Nantong University, Nantong, Jiangsu 226019, P. R. China
14 shared publications Jiachen Xia
College of Chemistry and Chemical Engineering Nantong University Nantong Jiangsu P.R. China
12 shared publicationsZhecheng Zhang
College of Chemistry and Chemical Engineering, Nantong University, No.9 Seyuan Road, Chongchuan District, Nantong, Jiangsu 226019, P. R. China
12 shared publications- Yue Ding
School of Chemistry and Chemical Engineering, Nantong University, Nantong, 226019, P. R. China
10 shared publications Yuying Huang
School of Chemistry and Chemical Engineering, Nantong University, Nantong, Jiangsu, 226019, P. R. China
10 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Wiley in ChemBioChem
- Vol. 27 (19) , e70538
The Strategies of Integrating 4‐Nitro‐3‐trifluoromethylaniline With Photosensitizers for Combined NO Gas and Photodynamic Therapy
Nowadays, an increasing number of emerging therapeutic modalities are flourishing due to the high recurrence and intractability of cancer. Among them, NO gas therapy (NO GT) relies on NO donors that release NO radicals upon external or internal stimulation. Photodynamic therapy (PDT) is realized by the specific photosensitizers and light source. However, the clinical translation of NO is limited by its gaseous nature and the need for precise control over dosage and spatiotemporal distribution. Meanwhile, the efficacy of PDT is often compromised by tumor hypoxia. Consequently, the synergistic integration of PDT and NO GT has emerged as a cutting‐edge paradigm in cancer treatment. Among the various NO donors, 4‐nitro‐3‐trifuoromethylaniline (NTA) and its derivatives, as a prominent class of NO photodonors, have garnered sustained attention, which displayed various advantages such as high and controllable NO release ability and outstanding structural modification. In this review, we highlight the design of such bimodal therapeutic systems based on two methods of the combination of NTA and photosensitizers, namely, nanoassembly and molecular hybridization. By elucidating the design principles and synergistic antitumor effects of these two strategies, we summarize future development directions and remaining bottlenecks to provide rational guidelines for subsequent molecular design and biomedical research.
- 30 September 2026
- Published by Wiley in ChemBioChem
- Vol. 27 (19) , e70538
Open AccessThe Strategies of Integrating 4‐Nitro‐3‐trifluoromethylaniline With Photosensitizers for Combined NO Gas and Photodynamic Therapy
Nowadays, an increasing number of emerging therapeutic modalities are flourishing due to the high recurrence and intractability of cancer. Among them, NO gas therapy (NO GT) relies on NO donors that release NO radicals upon external or internal stimulation. Photodynamic therapy (PDT) is realized by the specific photosensitizers and light source. However, the clinical translation of NO is limited by its gaseous nature and the need for precise control over dosage and spatiotemporal distribution. Meanwhile, the efficacy of PDT is often compromised by tumor hypoxia. Consequently, the synergistic integration of PDT and NO GT has emerged as a cutting‐edge paradigm in cancer treatment. Among the various NO donors, 4‐nitro‐3‐trifuoromethylaniline (NTA) and its derivatives, as a prominent class of NO photodonors, have garnered sustained attention, which displayed various advantages such as high and controllable NO release ability and outstanding structural modification. In this review, we highlight the design of such bimodal therapeutic systems based on two methods of the combination of NTA and photosensitizers, namely, nanoassembly and molecular hybridization. By elucidating the design principles and synergistic antitumor effects of these two strategies, we summarize future development directions and remaining bottlenecks to provide rational guidelines for subsequent molecular design and biomedical research.
- 13 May 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (45) , 11273-11284
The application of the pillararene-based GSH depletion strategy in tumor therapy
This short review outlines the commonly employed GSH depletion strategy in pillararene-based nanodrugs for tumor treatments and discusses the directions that can be pursued for further improvement of this field.
- 13 May 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (45) , 11273-11284
The application of the pillararene-based GSH depletion strategy in tumor therapy
This short review outlines the commonly employed GSH depletion strategy in pillararene-based nanodrugs for tumor treatments and discusses the directions that can be pursued for further improvement of this field.
- 21 February 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (23) , 6368-6372
Enhancing photodynamic therapy effects by a glutathione-responsive SO 2 donor as a nanocarrier for cancer therapy
Through the promotion of PDT efficacy mediated by the SO 2 gas therapy process, a simple, safe and robust photodynamic and SO 2 gas synergistic therapy nanoplatform was successfully built to complete highly efficient cancer therapy.
- 21 February 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (23) , 6368-6372
Enhancing photodynamic therapy effects by a glutathione-responsive SO 2 donor as a nanocarrier for cancer therapy
Through the promotion of PDT efficacy mediated by the SO 2 gas therapy process, a simple, safe and robust photodynamic and SO 2 gas synergistic therapy nanoplatform was successfully built to complete highly efficient cancer therapy.
- 6 August 2025
- Published by Wiley in Chemistry – A European Journal
- Vol. 31 (49) , e02117
The Application of PEG‐functionalized Amphiphilic Pillararene in Drug Delivery Systems
As a new generation of supramolecular host macrocyclic molecules, pillararenes display many advantages including simple synthesis routes, rigid electron‐rich structures, unique host‐guest interactions, and adjustable cavity sizes, which make them widely be used in drug delivery systems for precise diagnosis and treatment of cancer. The molecular functions of pillararenes can be easily expanded through the introduction of different functional groups into the side chain. For example, polyethylene glycol (PEG) which has good biocompatibility and water solubility can be used to construct PEG‐functionalized amphiphilic pillararenes. These PEG‐functionalized amphiphilic pillararenes can be used to construct the nanocarriers with good water solubility and excellent biocompatibility through their self‐assembly to deliver hydrophobic drugs. Although there are many reviews introducing the application of amphiphilic pillararenes in drug delivery, there are still no comprehensive articles summarizing such type of pillararenes. In this paper, based on their functional characteristics, the applications of PEG‐functionalized amphiphilic pillararene in drug delivery systems have been summarized. We focused on the relationship between their molecular design and functional application, providing reasonable guidance for the structural design of amphiphilic pillararenes.
- 6 August 2025
- Published by Wiley in Chemistry – A European Journal
- Vol. 31 (49) , e02117
The Application of PEG‐functionalized Amphiphilic Pillararene in Drug Delivery Systems
As a new generation of supramolecular host macrocyclic molecules, pillararenes display many advantages including simple synthesis routes, rigid electron‐rich structures, unique host‐guest interactions, and adjustable cavity sizes, which make them widely be used in drug delivery systems for precise diagnosis and treatment of cancer. The molecular functions of pillararenes can be easily expanded through the introduction of different functional groups into the side chain. For example, polyethylene glycol (PEG) which has good biocompatibility and water solubility can be used to construct PEG‐functionalized amphiphilic pillararenes. These PEG‐functionalized amphiphilic pillararenes can be used to construct the nanocarriers with good water solubility and excellent biocompatibility through their self‐assembly to deliver hydrophobic drugs. Although there are many reviews introducing the application of amphiphilic pillararenes in drug delivery, there are still no comprehensive articles summarizing such type of pillararenes. In this paper, based on their functional characteristics, the applications of PEG‐functionalized amphiphilic pillararene in drug delivery systems have been summarized. We focused on the relationship between their molecular design and functional application, providing reasonable guidance for the structural design of amphiphilic pillararenes.
- 10 July 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (32) , 9876-9882
ONOO− generator constructed with a small molecule photosensitizer and photoinduced NO donor for tumor therapy
Herein, a new small molecule photosensitizer (DMATPE-MN) and photoinduced NO donor (NTA-CN) were designed to construct a nanotherapeutic platform for highly efficient photodynamic and NO synergistic therapy through the generation of peroxynitrite.
- 10 July 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (32) , 9876-9882
ONOO− generator constructed with a small molecule photosensitizer and photoinduced NO donor for tumor therapy
Herein, a new small molecule photosensitizer (DMATPE-MN) and photoinduced NO donor (NTA-CN) were designed to construct a nanotherapeutic platform for highly efficient photodynamic and NO synergistic therapy through the generation of peroxynitrite.
- 5 March 2025
- Published by Springer Nature in Science China Materials
- Vol. 68 (4) , 1285-1291
Pillararene based supramolecular nanoplatform for endoplasmic reticulum-targeting type I photodynamic and NO gas therapy
- 5 March 2025
- Published by Springer Nature in Science China Materials
- Vol. 68 (4) , 1285-1291
Pillararene based supramolecular nanoplatform for endoplasmic reticulum-targeting type I photodynamic and NO gas therapy
- 1 November 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (95) , 14012-14021
Singlet oxygen storage and controlled release for improving photodynamic therapy against hypoxic tumor
Photodynamic therapy (PDT) is considered to be a promising tumor treatment method due to its non-invasiveness and low risk. However, there are two factors that affect the efficacy of this therapy. One is the light source and the other is the tumor hypoxia. An emerging PDT strategy has been developed to break these limits. This strategy is to adopt compounds, such as 2-pyridone, anthracene, and naphthalene derivatives, that have the ability to store and controlledly release the singlet oxygen (1O2) to achieve PDT in the dark. In this review, we focus on the construction strategies for integrated antitumor drugs containing these 1O2 storage/release units and photosensitizers and summarize their PDT performance in hypoxic tumors or in the dark. The methods to integrate these compounds with photosensitizers or nanocarriers are also discussed in detail to provide insightful design guidelines for the design of highly efficient antitumor systems based on 1O2 storage and controlled release.
- 1 November 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (95) , 14012-14021
Singlet oxygen storage and controlled release for improving photodynamic therapy against hypoxic tumor
Photodynamic therapy (PDT) is considered to be a promising tumor treatment method due to its non-invasiveness and low risk. However, there are two factors that affect the efficacy of this therapy. One is the light source and the other is the tumor hypoxia. An emerging PDT strategy has been developed to break these limits. This strategy is to adopt compounds, such as 2-pyridone, anthracene, and naphthalene derivatives, that have the ability to store and controlledly release the singlet oxygen (1O2) to achieve PDT in the dark. In this review, we focus on the construction strategies for integrated antitumor drugs containing these 1O2 storage/release units and photosensitizers and summarize their PDT performance in hypoxic tumors or in the dark. The methods to integrate these compounds with photosensitizers or nanocarriers are also discussed in detail to provide insightful design guidelines for the design of highly efficient antitumor systems based on 1O2 storage and controlled release.
- 13 July 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (65) , 8526-8536
Emerging A–D–A fused-ring photosensitizers for tumor phototheranostics
This feature article comprehensively summarizes the application of A–D–A photosensitizers in the field of phototheranostics from the perspectives of both molecular design and nanodrug construction.
- 13 July 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (65) , 8526-8536
Emerging A–D–A fused-ring photosensitizers for tumor phototheranostics
This feature article comprehensively summarizes the application of A–D–A photosensitizers in the field of phototheranostics from the perspectives of both molecular design and nanodrug construction.
- 24 June 2024
- Published by Springer Nature in Frontiers of Chemical Science and Engineering
- Vol. 18 (11) , 1-8
Active targeted drug delivery system constructed from functionalized pillararenes for chemo/photodynamic synergistic therapy
- 24 June 2024
- Published by Springer Nature in Frontiers of Chemical Science and Engineering
- Vol. 18 (11) , 1-8
Active targeted drug delivery system constructed from functionalized pillararenes for chemo/photodynamic synergistic therapy
- 12 April 2024
- Published by American Chemical Society (ACS) in ACS Macro Letters
- Vol. 13 (5) , 489-494
Side Chain Programming Synchronously Enhances the Photothermal Conversion Efficiency and Photodynamic Activity of A–D–A Photosensitizers
Synchronously improving the photothermal conversion efficiency and photodynamic activity of organic small molecule photosensitizers is crucial for their further wide application in cancer treatment. Recently, the emerging A-D-A photosensitizer-based phototherapy systems have attracted great interest due to their plentiful inherent merits. Herein, we propose a design strategy for A-D-A photosensitizers with synchronously enhanced photothermal conversion and reactive oxygen species (ROS) generation efficiencies. Side chain programming is carried out to design three A-D-A photosensitizers (IDT-H, IDT-Br, IDT-I) containing hexyl, bromohexyl, and iodohexyl side chains, respectively. Theoretical calculations confirm that a bulky iodine atom could weaken the intermolecular π-π stacking and enhance spin-orbit coupling constants of IDT-I. These molecular mechanisms enable IDT-I nanoparticles (NPs) to exhibit 2.4-fold and 1.7-fold higher ROS generation efficiency than that of IDT-H NPs and IDT-Br NPs, respectively, as well as the highest photothermal conversion efficiency. Both the experimental results in vitro and in vivo verify that IDT-I NPs are perfectly qualified for the mission of photothermal and photodynamic synergistic therapy. Therefore, in this contribution, we provide a promising perspective for the design of A-D-A photosensitizers with simultaneously improved photothermal and photodynamic therapy ability.
- 12 April 2024
- Published by American Chemical Society (ACS) in ACS Macro Letters
- Vol. 13 (5) , 489-494
Side Chain Programming Synchronously Enhances the Photothermal Conversion Efficiency and Photodynamic Activity of A–D–A Photosensitizers
Synchronously improving the photothermal conversion efficiency and photodynamic activity of organic small molecule photosensitizers is crucial for their further wide application in cancer treatment. Recently, the emerging A-D-A photosensitizer-based phototherapy systems have attracted great interest due to their plentiful inherent merits. Herein, we propose a design strategy for A-D-A photosensitizers with synchronously enhanced photothermal conversion and reactive oxygen species (ROS) generation efficiencies. Side chain programming is carried out to design three A-D-A photosensitizers (IDT-H, IDT-Br, IDT-I) containing hexyl, bromohexyl, and iodohexyl side chains, respectively. Theoretical calculations confirm that a bulky iodine atom could weaken the intermolecular π-π stacking and enhance spin-orbit coupling constants of IDT-I. These molecular mechanisms enable IDT-I nanoparticles (NPs) to exhibit 2.4-fold and 1.7-fold higher ROS generation efficiency than that of IDT-H NPs and IDT-Br NPs, respectively, as well as the highest photothermal conversion efficiency. Both the experimental results in vitro and in vivo verify that IDT-I NPs are perfectly qualified for the mission of photothermal and photodynamic synergistic therapy. Therefore, in this contribution, we provide a promising perspective for the design of A-D-A photosensitizers with simultaneously improved photothermal and photodynamic therapy ability.